drugset

drugset / Trial / NCT06506175

A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy Participants

NCT06506175 ↗

Phase 1 Not yet recruiting 100 enrolled Fujian Shengdi Pharmaceutical Co., Ltd.

RandomizedParallel-groupOpen-labelTreatment

Summary

The study is being conducted to evaluate the effects of different dosage regimen on the pharmacokinetics of HRS9531 tablets in healthy subjects.

Timeline

Start: 2026-07
Primary completion: 2026-09
Completion: 2026-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS9531	Unknown	—	—

Indications